BioSpace News Archive

Pharm Country

Annovis Bio to Study Potential of ANVS401 to Normalize Brain Development in Down Syndrome

Collaborative mice study with UC San Diego to study brain development from embryo to old age

April 29, 2021
·
5 min read
Drug Development

Vascular Therapies Announces Clinical Results From Its Phase 3 Randomized Multicenter Clinical Trial

Vascular Therapies, a privately held biotechnology company is developing Sirogen™, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels.

April 29, 2021
·
3 min read
Drug Development

Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds

James Lanthier, CEO of Mindset, commented, “N,N-dimethyltryptamine (DMT) & 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) are potent, short-acting psychedelic drugs that produce strong hallucinogenic effects.

April 29, 2021
·
4 min read
Telo Genomics Announces Co-Authored Publication of a Prospective 5-year Multiple Myeloma Study - Successfully Identifying High Risk versus Low Risk Smoldering Myeloma Patients

The study was recently published in the Scientific Journal titled “Cancers”.

April 29, 2021
·
5 min read
Policy

Government of Canada funds two new projects to encourage vaccine uptake in Canada

As we continue to roll out COVID-19 vaccines across the country, the Government of Canada is committed to addressing and reducing barriers to vaccination.

April 29, 2021
·
5 min read
Biotech Beach

Tryp Therapeutics Announces Q2 2021 Financial Results

Complete financial statements along with related management discussion and analysis can be found in the System for Electronic Document Analysis and Retrieval, the electronic filing system for the disclosure documents of issuers across Canada at www.SEDAR.com.

April 29, 2021
·
5 min read
Drug Development

Safe, Effective and Dose Responsive Anti-Viral Activity of OKG-0301 in Patients with Acute Adenoviral Conjunctivitis--Phase 2 Interim Analysis Results from RUBY Clinical Trial

In 58 patients diagnosed with acute adenoviral conjunctivitis, OKG-0301 was safe and demonstrated an effective, dose-dependent anti-viral response.

April 29, 2021
·
1 min read
Deals

Aveanna Commences Trading on Nasdaq

Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that its common stock has begun trading on the Nasdaq Global Select Market under the ticker symbol “AVAH.”

April 29, 2021
·
2 min read
Pharm Country

Geisinger awarded $3.6 million to study genetics of cancer

Contract with National Cancer Institute will leverage data from Geisinger’s MyCode Community Health Initiative

April 29, 2021
·
3 min read
Business

BioMarin Announces First Quarter 2021 Financial Results and Corporate Updates

FDA Review of Vosoritide Proceeding; PDUFA Target Action Date Extended to November 20, 2021 to Provide Time for Review of Recently Submitted 2-year Phase 3 Results

April 29, 2021
·
25 min read